Estimates Revisions Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Stocks
600196
CNE000000X38
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
23/09/2026
|
5-day change | 1st Jan Change | ||
| 23.13 CNY | 0.00% |
|
+6.30% | -12.68% |
| 09-23 | Shanghai Fosun Unit Gets Global License for Two TCE Cancer Products | MT |
| 09-14 | Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5% | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
Select your edition
All financial news and data tailored to specific country editions
